Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of GEN0101 plus cisplatin + pemetrexed in unresectable malignant pleural mesothelioma
jRCT2080224548Phase 2Completed
- Sponsor
- Osaka Toneyama Medical Center
- Start
- Feb 2019
- Modality
- Oncolytic Viruses → Oncolytic Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label trial of GEN0101 in pleural mesothelioma (2 arms), sponsored by Osaka Toneyama Medical Center. Started Feb 2019; status: completed.
02
Drugs
GEN0101
03
Conditions
pleural mesothelioma
Beyond the preview
Go deeper on jRCT2080224548.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080224548.